AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹108 Cr | ₹79 Cr | ₹71 Cr | - |
What is the latest Deferred Tax Assets / Liabilities ratio of AARTI PHARMALABS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹108 Cr |
Mar2023 | ₹79 Cr |
Mar2022 | ₹71 Cr |
Mar2021 | - |
How is Deferred Tax Assets / Liabilities of AARTI PHARMALABS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹108 Cr | 36.89 | |
Mar2023 | ₹79 Cr | 11.56 | |
Mar2022 | ₹71 Cr | 0 | |
Mar2021 | - | - |
Compare Deferred Tax Assets / Liabilities of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹8,356.9 Cr | -1.5% | 7.4% | 60.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,595.0 Cr | 1.5% | 0.9% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,635.0 Cr | -0.5% | -1.2% | 45.5% | Stock Analytics | |
CIPLA | ₹126,894.0 Cr | 7.2% | 4.5% | 2.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,685.0 Cr | 3.5% | 8.4% | 16.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,373.0 Cr | 3.7% | -1.1% | -6.8% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | -1.5% |
7.4% |
60.8% |
SENSEX | -1.6% |
-3.4% |
0.9% |
You may also like the below Video Courses